Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong
1 other identifier
observational
100,000
1 country
1
Brief Summary
This study aims to develop predictive models for patients with a diagnosis of COPD at discharge of an index admission on these outcomes using machine learning: Primary outcome: Early admission Secondary outcomes:
- 1.Frequent readmission
- 2.Composite outcome (Early + Frequent readmissions)
- 3.Mortality
- 4.Longstayers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2023
CompletedStudy Start
First participant enrolled
August 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
March 18, 2026
March 1, 2026
3.7 years
April 11, 2023
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Early Readmission
Patients were readmitted to hospital with the primary diagnosis of AECOPD\* within 30 days since the discharge date of the index admission
30 days
Secondary Outcomes (3)
Frequent Admitters
365 days
1-Year Mortality
365 days
Longstayers
365 days
Interventions
No intervention
Eligibility Criteria
Patients are discharged from 2016 -2022 from hospital for acute exacerbation of COPD
You may qualify if:
- ≥40 years
- Patients are discharged from 2016 -2022
- Discharge Diagnosis: Using the Discharge Diagnosis ICD Codes found in the Primary Diagnosis to determine if a patient has COPD
- Validated against Spirometry results (for patient with a spirometry reading):
- Spirometry reading taken from anytime point before. Patient should have Post FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings. If Post FEV1/FVC is not available, we will check if patients have a Pre FEV1/FVC value, and will also include patients with Pre FEV1/FVC ratio of \< 0.7 in any one of the spirometry readings.
You may not qualify if:
- Admission diagnosis due to causes other than COPD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, New Territories, Hong Kong
Study Officials
- STUDY DIRECTOR
David Hui, MD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Clinical Associate Professor
Study Record Dates
First Submitted
April 11, 2023
First Posted
April 24, 2023
Study Start
August 29, 2023
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2028
Last Updated
March 18, 2026
Record last verified: 2026-03